P. Snoy

1.3k total citations
18 papers, 1.1k citations indexed

About

P. Snoy is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, P. Snoy has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in P. Snoy's work include Viral gastroenteritis research and epidemiology (4 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). P. Snoy is often cited by papers focused on Viral gastroenteritis research and epidemiology (4 papers), Immunotherapy and Immune Responses (4 papers) and Hepatitis B Virus Studies (4 papers). P. Snoy collaborates with scholars based in United States, United Kingdom and Japan. P. Snoy's co-authors include Jeffrey Schlom, Takashi Yokota, Steven W. Dodd, James F. Wood, Diane E. Milenic, Malcolm Finkelman, Marc Whitlow, David Filpula, Robert J. Gerety and Edward Tabor and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Brain Research.

In The Last Decade

P. Snoy

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Snoy United States 14 305 303 288 280 233 18 1.1k
Björn Löwenadler Sweden 21 441 1.4× 160 0.5× 275 1.0× 596 2.1× 179 0.8× 28 1.5k
Catherine Fayolle France 22 521 1.7× 119 0.4× 189 0.7× 761 2.7× 144 0.6× 40 1.4k
K Fujiwara Japan 19 503 1.6× 79 0.3× 623 2.2× 172 0.6× 66 0.3× 70 1.6k
J. P. Kraehenbuhl Switzerland 16 620 2.0× 78 0.3× 200 0.7× 377 1.3× 199 0.9× 22 1.5k
David S. Burt Canada 27 354 1.2× 182 0.6× 333 1.2× 778 2.8× 53 0.2× 53 1.6k
Ivo C. Lorenz United States 16 250 0.8× 89 0.3× 304 1.1× 145 0.5× 30 0.1× 33 1.1k
Emily K. Forbes United Kingdom 15 369 1.2× 46 0.2× 338 1.2× 456 1.6× 63 0.3× 28 1.1k
Greg A. Snyder United States 18 294 1.0× 74 0.2× 167 0.6× 491 1.8× 58 0.2× 30 956
Philippe Thullier France 25 753 2.5× 525 1.7× 292 1.0× 306 1.1× 45 0.2× 50 1.6k
K L Rosenthal Canada 19 211 0.7× 97 0.3× 180 0.6× 606 2.2× 23 0.1× 28 1.1k

Countries citing papers authored by P. Snoy

Since Specialization
Citations

This map shows the geographic impact of P. Snoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Snoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Snoy more than expected).

Fields of papers citing papers by P. Snoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Snoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Snoy. The network helps show where P. Snoy may publish in the future.

Co-authorship network of co-authors of P. Snoy

This figure shows the co-authorship network connecting the top 25 collaborators of P. Snoy. A scholar is included among the top collaborators of P. Snoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Snoy. P. Snoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Snoy, P.. (2010). Establishing Efficacy of Human Products Using Animals. Veterinary Pathology. 47(5). 774–778. 84 indexed citations
2.
Fisher, Robert W., Jennifer L. Reed, P. Snoy, et al.. (2010). Postexposure Prevention of Progressive Vaccinia in SCID Mice Treated with Vaccinia Immune Globulin. Clinical and Vaccine Immunology. 18(1). 67–74. 14 indexed citations
3.
Westergaard, G. C., et al.. (2004). Biobehavioural correlates of hand preference in free‐ranging female primates. Laterality Asymmetries of Body Brain and Cognition. 9(3). 267–285. 15 indexed citations
4.
Devi, S J, W D Zollinger, P. Snoy, et al.. (1997). Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys. Infection and Immunity. 65(3). 1045–1052. 37 indexed citations
5.
Puri, Raj K., Dave S.�B. Hoon, Pamela Leland, et al.. (1996). Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.. PubMed. 56(24). 5631–7. 93 indexed citations
6.
Barile, Michael F., et al.. (1994). Experimentally Induced Septic Arthritis in Chimpanzees Infected with Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum. Clinical Infectious Diseases. 18(5). 694–703. 10 indexed citations
7.
Biswas, Robin, et al.. (1994). The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion. 34(2). 100–104. 15 indexed citations
8.
9.
Heyes, Melvyn P., Elaine Jordan, Kuniaki Saito, et al.. (1992). Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Research. 570(1-2). 237–250. 83 indexed citations
10.
Kantor, Judy, Kari R. Irvine, Scott I. Abrams, et al.. (1992). Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.. PubMed. 52(24). 6917–25. 69 indexed citations
11.
Kotloff, Karen L., D A Herrington, Thomas L. Hale, et al.. (1992). Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infection and Immunity. 60(6). 2218–2224. 66 indexed citations
12.
Ansher, Sherry S., Walter C. Thompson, P. Snoy, & W H Habig. (1992). Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infection and Immunity. 60(9). 3790–3798. 13 indexed citations
13.
Formal, S. B., et al.. (1991). Effect of Prior Infection with Virulent Shigella flexneri 2a on the Resistance of Monkeys to Subsequent Infection with Shigella sonnei. The Journal of Infectious Diseases. 164(3). 533–537. 112 indexed citations
14.
Milenic, Diane E., Takashi Yokota, David Filpula, et al.. (1991). Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.. PubMed. 51(23 Pt 1). 6363–71. 274 indexed citations
15.
Einarsson, Monica, et al.. (1987). Chromatographic removal of hepatitis B virus from a factor IX concentrate. Transfusion. 27(2). 171–173. 1 indexed citations
16.
Iwarson, Sten, Edward Tabor, Howard C. Thomas, P. Snoy, & Robert J. Gerety. (1985). Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology. 88(3). 763–767. 87 indexed citations
17.
Formal, Samuel B., Thomas L. Hale, C Kapfer, et al.. (1984). Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infection and Immunity. 46(2). 465–469. 71 indexed citations
18.
Tabor, Edward, P. Snoy, Daniel Jackson, et al.. (1984). Additional evidence for more than one agent of human non‐A, non‐B hepatitis. Transmission and passage studies in chimpanzees. Transfusion. 24(3). 224–230. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026